**Calpro Unveils “CalproSmart” for IBD Monitoring**
Norwegian-based Calpro showcased “CalproSmart” at DMEA 2025, a home-testing device for IBD patients. This allows remote monitoring by physicians, potentially improving treatment adherence and reducing hospital visits. The company also introduced a blood test, expanding its diagnostic offerings. Production sites are in the UK and Sweden.
Generated by Gemini
DMEA Web Site:https://www.dmea.de/en/
DMEA (Digital Medical Expertise & Applications) is the largest digital health event in Europe, where key players driving digitalization in the medical field come together. In 2025, DMEA will be held under the theme of **”Connecting Digital Health”**, where the latest technologies, innovative solutions, and visions for shaping the future of healthcare intersect.
* **Comprehensive exhibitions:** A wide range of products and services will be gathered under one roof, including IT solutions for hospitals, mobile health, AI, cybersecurity, and big data.
* **Rich conferences:** Industry leaders and experts will share the latest trends, challenges, and success stories through talks, panel discussions, and workshops.
* **Networking:** We provide opportunities to interact with a diverse range of participants, including medical institutions, pharmaceutical companies, insurance companies, startups, and research institutions.
* **Future-oriented themes:** In 2025, the focus will be on personalized medicine using AI and data, the evolution of telemedicine, and improving patient experience brought about by digital health.
DMEA is a great opportunity to experience the cutting edge of the digital health field and create the future of medicine together. Why not share your innovative solutions with the world at the next DMEA and seize new business opportunities? We look forward to your visit and participation. For more information, please visit our official website https://www.dmea.de/en/.
Generated by Gemini
